Results 311 to 320 of about 82,828 (358)

Ovarian Carcinomas with Transitional Cell Carcinoma Patter

American Journal of Clinical Pathology, 1990
The authors report 88 cases of ovarian carcinoma containing areas of transitional cell carcinoma (TCC). The tumors were found in women 28-76 years old (mean, 51 years). Fifteen patients presented with stage II, 59 with stage III, and 14 with stage IV disease. Ten neoplasms were composed of only TCC, 48 were predominantly TCC, and 30 had foci of TCC but
E G, Silva, S S, Robey-Cafferty, T L, Smith, D M, Gershenson   +3 more
openaire   +2 more sources

Retroperitoneal urogenital ridge transitional cell carcinoma

Journal of Surgical Oncology, 1983
AbstractA rare case of retroperitoneal transitional cell carcinoma arising from primitive urogenital remnants is described in a 50‐year‐old female. The patient had a 15 × 12 cm firm to cystic mass in the left iliac fossa which was markedly adherent to retroperitoneal structures and which could not be excised.
S, Gupta, S, Gupta, K, Sahni
openaire   +2 more sources

Management of transitional cell carcinoma

Veterinary Clinics of North America: Small Animal Practice, 2003
Canine TCC of the bladder is a disease for which early detection and multimodality therapy are likely to produce the most favorable results. Urine screening tests are being investigated as tools to permit earlier detection. The possibility of tumor seeding must be considered when obtaining urine for analysis and when performing surgery.
openaire   +2 more sources

Transitional cell carcinoma

Transitional cell carcinoma (TCC), or urothelial carcinoma, is the predominant form of bladder cancer, accounting for 90-95% of global cases. It ranks as the fourth most common cancer in men and the tenth in women in the United States, with higher incidences in developed regions.
openaire   +1 more source

CLEAR‐CELL TRANSITIONAL CELL CARCINOMA

Australian and New Zealand Journal of Surgery, 1997
K G, Braslis, A, Jones, D, Murphy
openaire   +2 more sources

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Transitional cell carcinoma

2023
openaire   +1 more source